Pregnancy induction with pulsatile gonadotropin releasing hormone pump (GNRH) therapy in a patient with a KISS1 receptor mutation associated normosmic congenital hypogonadotropic hypogonadism and a very low anti-mullerian hormone: A Case Study
Hybrid acylated and non-acylated GLP-1 and apelin receptor co-agonist peptides, show promising acute in vivo anti-hyperglycaemic actions in normal healthy and insulin resistant diet-induced obese mice.
Oral Presentation: The relation of microvascular complications to a new interpretation of glycaemic variability from continuous glucose monitoring in people with type 1 diabetes (T1D)
Oral Presentation: Investigation of the differential impact of oral classic and 11-oxygenated androgen precursor administration on downstream androgen metabolism and insulin sensitivity in women with polycystic ovary syndrome (PCOS)
Oral Presentation: Once-daily oral administration of gpr55 agonist ml-184 has direct and indirect benefits on β-cell and gastrointestinal health in obese-diabetic mice
Associations between Fear of Hypoglycaemia and Step-Count Among Adults with Type 1 Diabetes and Insulin-Treated Type 2 Diabetes: Findings from the Hypo-METRICS Study
Oral Presentation: Gonadotropin Rise Following Intranasal Kisspeptin Administration Is Increased in Women With Hypothalamic Amenorrhoea Compared to Healthy Women
Crinecerfont, a Corticotropin-Releasing Factor Type 1 Receptor (CRF1) Antagonist, Reduced Excess Adrenal Androgens and Enabled Glucocorticoid Dose Reductions in Adults with Classic Congenital Adrenal Hyperplasia: Results from CAHtalyst™
Pregnancy induction with pulsatile gonadotropin releasing hormone pump (GNRH) therapy in a patient with a KISS1 receptor mutation associated normosmic congenital hypogonadotropic hypogonadism and a very low anti-mullerian hormone: A Case Study
Oral Presentation: Once-daily oral administration of gpr55 agonist ml-184 has direct and indirect benefits on β-cell and gastrointestinal health in obese-diabetic mice
Oral Presentation: Gonadotropin Rise Following Intranasal Kisspeptin Administration Is Increased in Women With Hypothalamic Amenorrhoea Compared to Healthy Women
Oral Presentation: The relation of microvascular complications to a new interpretation of glycaemic variability from continuous glucose monitoring in people with type 1 diabetes (T1D)
Associations between Fear of Hypoglycaemia and Step-Count Among Adults with Type 1 Diabetes and Insulin-Treated Type 2 Diabetes: Findings from the Hypo-METRICS Study
Oral Presentation: Investigation of the differential impact of oral classic and 11-oxygenated androgen precursor administration on downstream androgen metabolism and insulin sensitivity in women with polycystic ovary syndrome (PCOS)
Hybrid acylated and non-acylated GLP-1 and apelin receptor co-agonist peptides, show promising acute in vivo anti-hyperglycaemic actions in normal healthy and insulin resistant diet-induced obese mice.
Crinecerfont, a Corticotropin-Releasing Factor Type 1 Receptor (CRF1) Antagonist, Reduced Excess Adrenal Androgens and Enabled Glucocorticoid Dose Reductions in Adults with Classic Congenital Adrenal Hyperplasia: Results from CAHtalyst™
Pregnancy induction with pulsatile gonadotropin releasing hormone pump (GNRH) therapy in a patient with a KISS1 receptor mutation associated normosmic congenital hypogonadotropic hypogonadism and a very low anti-mullerian hormone: A Case Study
Oral Presentation: The relation of microvascular complications to a new interpretation of glycaemic variability from continuous glucose monitoring in people with type 1 diabetes (T1D)
Oral Presentation: Gonadotropin Rise Following Intranasal Kisspeptin Administration Is Increased in Women With Hypothalamic Amenorrhoea Compared to Healthy Women
Hybrid acylated and non-acylated GLP-1 and apelin receptor co-agonist peptides, show promising acute in vivo anti-hyperglycaemic actions in normal healthy and insulin resistant diet-induced obese mice.
Associations between Fear of Hypoglycaemia and Step-Count Among Adults with Type 1 Diabetes and Insulin-Treated Type 2 Diabetes: Findings from the Hypo-METRICS Study
Crinecerfont, a Corticotropin-Releasing Factor Type 1 Receptor (CRF1) Antagonist, Reduced Excess Adrenal Androgens and Enabled Glucocorticoid Dose Reductions in Adults with Classic Congenital Adrenal Hyperplasia: Results from CAHtalyst™
Oral Presentation: Investigation of the differential impact of oral classic and 11-oxygenated androgen precursor administration on downstream androgen metabolism and insulin sensitivity in women with polycystic ovary syndrome (PCOS)
Oral Presentation: Once-daily oral administration of gpr55 agonist ml-184 has direct and indirect benefits on β-cell and gastrointestinal health in obese-diabetic mice